Browse > Article

An Analysis of the Existing Guidelines and Clinical Trials for the Development of the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD)  

Han, Ga-jin (Dept. of Gastroenterology, College of Korean Medicine, Kyung-Hee University)
Leem, Jung-tae (Korean Medicine Clinical Trial Center, Kyung-Hee University Korean Medicine Hospital)
Kim, Jin-sung (Dept. of Gastroenterology, College of Korean Medicine, Kyung-Hee University)
Lee, Jun-hee (Korean Medicine Clinical Trial Center, Kyung-Hee University Korean Medicine Hospital)
Publication Information
The Journal of Internal Korean Medicine / v.37, no.1, 2016 , pp. 90-108 More about this Journal
Abstract
Objectives: This study aimed to learn what should be considered in the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD) by analyzing the existing guidelines and clinical trials.Methods: The development committee searched the existing guidelines for herbal medicinal products or GERD. Then, clinical trials related to GERD using herbal medicine were selected. The chosen trials were analyzed in terms of their inclusion and exclusion of participants, intervention, comparators, outcome, and trial design. Then, we compared the results of the analysis according to the regulations and guidelines of the Ministry of Food and Drug Safety to suggest the issues that we will have to consider when developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD).Results: As a result, few guidelines for GERD and clinical trials with herbal medicinal products were located in the national institution homepage. In addition, 8 articles were found using the following combination of search terms: “Gastroesophageal reflux disease”, “GERD”, “herbal medicine”, “herbal therapy”, “Korean Medicine”, “Traditional Chinese Medicine”, and “TCM”. Even though all trials had their own unique research questions, all studies were performed using a randomization method. Most trials included participants with reflux esophagitis, but two trials targeted proton pump inhibitor-refractory GERD. The type of intervention varied, such as decoction, granules, and capsules. Additionally, individualized herbal medicines were used in two studies. Comparators were diverse, such as placebo, Western medicine, and electro-acupuncture. The most frequently used outcome for efficacy was the effectiveness rate. In addition, the outcome for evaluating quality of life, esophageal mucosa and pressure, esophageal acid reflux, and recurrence rates were used. Safety was investigated by recording adverse events and carrying out laboratory tests.Conclusions: We identified some issues by reviewing the existing guidelines and comparing them with clinical trials for GERD and herbal medicinal products. These results will be utilized for developing the Guidelines of Clinical Trials with Herbal Medicinal Products for Gastroesophageal Reflux Disease (GERD).
Keywords
gastroesophageal reflux disease (GERD); herbal medicinal products; clinical trial; guideline;
Citations & Related Records
Times Cited By KSCI : 7  (Citation Analysis)
연도 인용수 순위
1 김지현, 김범진, 김상욱, 김성은, 김연수, 성혜영, 등. 위식도역류질환의 최근 동향. Korean J Gastroenterol 2014;64(3):127-32.   DOI
2 Cho YS, Choi MG, Jeong JJ, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 2005;100(4):747-53.   DOI
3 정혜경, 홍수진, 조윤주, 전성우, 조유경, 이광재, 등. 위식도역류질환 임상진료지침 개정안 2012. 대한소화기기능성질환·운동학회. 대한소화기학회지 2012;60(4):195-218.   DOI
4 이준행, 조유경, 전성우, 김지현, 김나영, 이준성, 등. 위식도역류질환의 치료에 관한 임상진료지침. 대한소화기학회지 2011;57(2):57-66.   DOI
5 Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005:CD003245.
6 Fass R, Gasiorowska A. Refractory GERD: what is it? Curr Gastroenterol Rep. 2008;10(3) :252-7.   DOI
7 Hayden C, Bernstein C, Hall R, Vakil N, Garewal HS, Fass R. Usage of supplemental alternative medicine by community-based patients with gastroesophageal reflux disease (GERD). Dig Dis Sci 2002;47(1):1-8.   DOI
8 Committee on the publishing text of Korean Internal Medicine on Spleen, Internal Medicine on Spleen, 1st edition. Seoul: Koonja Publishing Inc; 2009, p. 314-8.
9 한가진, 임정태, 이나라, 김진성, 박재우, 이준희. 위식도역류질환 변증도구개발. 대한한방내과학회지 2015;36(2):122-52.
10 한국보건산업진흥원. 국내의약품임상시험현황 및 전망. 서울: 한국보건산업진흥원; 2006, p. 7-14.
11 Lee JE, Park JH, Cho HS, Kim JC, Oh SW, Lee SH, et al. A Case Report of Gastroesophageal Reflux Disease(GERD) with Hiatal Hernia. Korean J Orient Int Med 2005;26(1):244-51.
12 Kim YH, Kim SY, Hwang MW. A Case Study of Taeumin Patient with Gastro-esophageal reflux disease(GERD) who Treated Successfully with Yeoldahanso-tang(Reduohanshao-tang). J of Sasang Constitutional Medicine 2011;23(1) :132-8.
13 식품의약품안전처 식품의약품안전평가원 의약품심사부 소화계약품과. 위식도역류질환 치료제의 임상시험평가 가이드라인. 청주: 식품의약품안전처; 2014.
14 정희, 이지형, 장보형, 고성규. 성요한초제제 임상시험 고찰을 통한 한약기원 항우울제 임상시험 방법론 연구. 대한한방내과학회지 2007;28(2) :363-76.
15 식품의약품안전청 생약평가부. 생약(한약)제제 임상시험의 일반적 고려사항. 서울: 식품의약품안전청; 2007.
16 한국한의학연구원. 천연물신약⋅한약제제임상시험가이드라인 연구. 서울: 식품의약품안전청;2004.
17 경희대학교산학협력단. 한약제제의 임상시험평가지표개발에 관한 연구. 서울: 식품의약품안전청; 2006.
18 Tominaga K, Iwakiri R, Fujimoto K, Fujiwara Y, Tanaka M, Shimoyama Y, et al. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol 2012;47(3):284-92.   DOI
19 Ghen JY, Qiu JR, Pan F. Clinical observation on treatment of gastro-esophageal reflux with modified zhizhu pill. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004;24(1):25-7.
20 Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, et al. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol 2014; 49(10):1392-405.   DOI
21 Zhang Q, Tan XP, Wang WZ. Clinical effects of dalitong granule combined proton pump inhibitors on gastroesophageal reflux disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 2012; 32(4):464-7.
22 Xu HR, Bo P, Yuan Y. Study on integrated Chinese and Western therapy and criterion for efficacy evaluation of gastroesophageal reflux disease-a clinical observation on 116 cases. Zhongguo Zhong Xi Yi Jie He Za Zhi 2007; 27(3):204-7.
23 Zhai XH, Shu Q, Deng JM, Wu C, Tang B, An H, et al. Clinical observation on treatment of reflux gastro-esophagitis by syndrome-differentiation depending therapy of TCM. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004; 24(11):1014-5.
24 Zhang C, Guo L, Guo X, Guo X, Li G. Clinical curative effect of electroacupuncture combined with Zhizhukuanzhong Capsules for treating gastroesophageal reflux disease. J Tradit Chin Med 2012;32(3):364-71.   DOI
25 Zhang CX, Guto LK, Guo BR.Clinical efficacy of electroacupuncture combined with dalitong granule for gastroesophageal reflux disease and its mechanism. Zhongguo Zhen Jiu 2012 Jun; 32(6):491-8.
26 Kusano M, Shimoyama Y, Sugimoto S, Kawamura O, Maeda M, Minashi K, et al. Development and evaluation of FSSG; frequency scale for the symptoms of GERD. J Gastroenterol 2004; 39:888-91.   DOI
27 Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.   DOI
28 Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment. J Clin Gastroemterol 2007;41:437-44.   DOI
29 Johnson LF, DeMeester TR. Development of 24-hour pH monitoring of the distal esophagus. Am J Gastrenterol 1974;6l:325-30.
30 Savary M, Miller G. The Esophagus. Handbook and Atlas of Endoscopy. Solothurn: Gassmann Verlag, AG; 1978.
31 Chinese Society of Gastrointestinal Endoscopy. Crietrion of di-agnosis and treatment for gastroesophageal reflux disease／reflux esophagitis (trial). Chin J Gastroenterol 2000;5(4):25l.
32 陆再英, 钟南山. 内科学 ７版. 北京: 人民卫生出版社; 2008, p. 372-75.
33 Hu J, Gruber KJ, Hsueh KH. Psychometric properties of the Chinese version of the SF-36 in older adults with diabetes in Beijing, China. Diabetes Res Clin Pract 2010;88(3):273-81.   DOI
34 DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005;100:190-200.   DOI
35 김나영. 위식도역류질환 update. 제9회 분당서울대학교병원 내과 연수강좌. 2012:85-93.
36 Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130(5):1538-51.   DOI
37 Vakil NB, Halling K, Becher A, Rydén A. Systematic review of patient-reported outcome instruments for gastroesophageal reflux disease symptoms. Eur J Gastroenterol Hepatol 2013; 25(1):2-14.   DOI
38 Mouli VP1, Ahuja V. Questionnaire based gastroesophageal reflux disease (GERD) assessment scales. Indian J Gastroenterol 2011;30(3):108-17.   DOI